| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/01/2000 | US6096772 Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms |
| 08/01/2000 | US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 08/01/2000 | US6096755 N-substituted azabicycloalkane derivatives, their preparation and use |
| 08/01/2000 | US6096754 N-3 substituted pyrimidin-4-ones with AII antagonistic activity |
| 08/01/2000 | US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives |
| 08/01/2000 | US6096743 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 08/01/2000 | US6096739 Treatment for CNS injuries |
| 08/01/2000 | US6096736 Benzazepine derivatives with vasopressin agonistic activity |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096689 5-pyrazolylbenzoic acid derivatives as herbicides |
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
| 08/01/2000 | CA2199845C Quinoxalinedione nmda receptor antagonists |
| 08/01/2000 | CA2133762C Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | WO2000043386A1 Cationic di-benzene dyeing agents, use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing method |
| 07/27/2000 | WO2000043385A1 Heterocyclic compounds and antitumor agents containing the same as the active ingredient |
| 07/27/2000 | WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents |
| 07/27/2000 | WO2000043374A1 Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043367A1 Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods |
| 07/27/2000 | WO2000043366A1 Quinoline derivatives and quinazoline derivatives |
| 07/27/2000 | WO2000043004A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | WO2000042849A1 COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR AND SULFOBUTYLETHER-7-β-CYCLODEXTRIN OR 2-HYDROXYPROPYL-β-CYCLODEXTRIN AND METHOD |
| 07/27/2000 | WO2000018767A3 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 07/27/2000 | WO2000012500A3 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 07/27/2000 | CA2361115A1 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | CA2322998A1 Cationic di-benzene dyeing agents, use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing method |
| 07/26/2000 | EP1022270A1 Pyrazole derivatives |
| 07/26/2000 | EP1021437A1 Arylsulfonylimidazolone derivatives as an antitumor agent |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021405A1 Azetidinone derivatives for the treatment of hcmv infections |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP1021188A1 Inhibitors of prenyl-protein transferase |
| 07/26/2000 | EP1021185A1 Didhydropyrimidines and uses thereof |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021173A1 Use of csaid?tm compounds for the management of uterine contractions |
| 07/26/2000 | EP0827503B1 Pyrrolidinyl methyl indole salt |
| 07/26/2000 | EP0556393B1 Fused pyrazine derivative |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
| 07/26/2000 | CN1261287A Pharmaceutical formulations containing voriconazole |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1054844C N-substituted azabicycloheptane derivatives, their preparation and use |
| 07/25/2000 | US6093822 5-arylindole derivatives |
| 07/25/2000 | US6093812 Process for the stereospecific synthesis of azetidinones |
| 07/25/2000 | US6093737 2-oxo-piperidine substituted imidazole derivatives |
| 07/25/2000 | US6093735 Selective β-3 adrenergic agonists |
| 07/25/2000 | US6093727 A selective agonists for human alpha 2 receptors for treating disorders as hypertension, pain, glaucoma, alcohol and drug withdrawal, ischemia, rheumatoid arthritis, migraine, cognitive deficiency, spasticity, diarrhea, nasal congestion |
| 07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 07/25/2000 | CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives |
| 07/25/2000 | CA2141029C Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 07/20/2000 | WO2000042059A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | WO2000042038A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042037A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042036A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | WO2000042026A1 Non-peptide glp-1 agonists |
| 07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
| 07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea |
| 07/20/2000 | WO2000041992A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/20/2000 | CA2359952A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359942A1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/20/2000 | CA2359569A1 Reductive alkylation of secondary amines with hydrosilane |
| 07/20/2000 | CA2359416A1 6-arylphenanthridines with pde-iv inhibiting activity |
| 07/20/2000 | CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/19/2000 | EP1020462A1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 07/19/2000 | EP1020453A1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid deri vatives, addition salts thereof, and processes for the preparation of both |
| 07/19/2000 | EP1020450A1 Method of manufacturing a 3-substituted-3-oxo-2-halopropionic acid amide compound and method of manufacturing a 3-substituted-3-oxo-2-(5,5-dimethylhydantoin-3-yl) propionic acid amide compound |
| 07/19/2000 | EP1020447A1 Pyrazole compounds and plant disease control agent |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019530A1 A method of treating cancer |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019393A1 Novel synthesis |
| 07/19/2000 | EP1019383A2 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 07/19/2000 | EP1019382A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| 07/19/2000 | EP1019372A1 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019048A1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 07/19/2000 | EP1019047A1 Antithrombotic agents |
| 07/19/2000 | EP1019045A1 Antithrombotic agents |
| 07/19/2000 | EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS |
| 07/19/2000 | EP0821682B1 Benzimidazole compounds and their use as modulators of the gaba-a receptor complex |
| 07/19/2000 | EP0735877B1 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260781A Indole derivatives having combined 5HT1A, 5HT1B and 5HT1D receptor antagoinist activity |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090941 Pharmaceutically active benzoquinazoline compounds |
| 07/18/2000 | US6090813 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |